Comparative analysis of primary versus relapse/refractory DLBCL identifies shifts in mutation spectrum.
Oncotarget
Greenawalt, Danielle M DM; Liang, Winnie S WS; Saif, Sakina S; Johnson, Justin J; Todorov, Petar P; Dulak, Austin A; Enriquez, Daniel D; Halperin, Rebecca R; Ahmed, Ambar A; Saveliev, Vladislav V; Carpten, John J; Craig, David D; Barrett, J Carl JC; Dougherty, Brian B; Zinda, Michael M; Fawell, Stephen S; Dry, Jonathan R JR; Byth, Kate K
The potential impact of adding genetic markers to clinical parameters in managing high-risk prostate cancer patients.
Springerplus
Alvarez-Cubero, Maria Jesus MJ; Martinez-Gonzalez, Luis Javier LJ; Vazquez-Alonso, Fernando F; Saiz, Maria M; Alvarez, Juan Carlos JC; Lorente, Jose Antonio JA; Cozar, Jose Manuel JM